Global Landscape

The first few weeks of 2026 have brought significant developments from the FDA and EMA, from landmark AI collaborations to proactive measures for strengthening domestic manufacturing and securing drug supplies.

Understanding the Regulatory Landscape with Medical Device Consulting Services. Regulations vary by region, but the core principles remain consistent: safety, efficacy, and quality. For example, in the UK and Europe, the Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) set stringent requirements. In the US, the FDA’s Quality System Regulation (QSR) governs device manufacturing and controls.

A well-structured strategy is the backbone of successful international expansion. It involves thorough market research, competitive analysis, and a clear entry plan. Here are the critical steps to consider:

The pharmaceutical industry in Mexico is on the brink of significant change thanks to the reliance regulatory pathway introduced by the Federal Commission for the Protection against Sanitary Risks (COFEPRIS). This new approach is designed to make the approval processes for clinical research protocols